Data gathered: January 14
Alternative Data for Grail
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 19 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 55,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 64 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 7 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,160 | Sign up | Sign up | Sign up |
| Instagram Followers | 237 | Sign up | Sign up | Sign up |
| Reddit Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 540 | Sign up | Sign up | Sign up |
| Threads Followers | 36 | Sign up | Sign up | Sign up |
| Twitter Followers | 16,878 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,300 | Sign up | Sign up | Sign up |
| News Mentions | 4 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 31 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,208 | Sign up | Sign up | Sign up |
About Grail
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection.
| Price | $18.57 |
| Target Price | Sign up |
| Volume | 1,010,000 |
| Market Cap | $596M |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Vacheron Constantin Drops the ’70s Grail We’ve Been Waiting Decades ForJanuary 13 - Highsnobiety |
 |
Head to Head Analysis: Enzo Biochem (NYSE:ENZ) and Grail (NASDAQ:GRAL)January 10 - ETF Daily News |
 |
A ‘Holy Grail’ of Science Is Getting CloserJanuary 9 - The Atlantic |
 |
Silver Grail Resources (CVE:SVG) Sets New 52-Week Low – What’s Next?January 5 - ETF Daily News |
|
Grail (NASDAQ:GRAL) Shares Down 6.7% – What’s Next?December 30 - ETF Daily News |
 |
Aviation’s Holy Grail: Turning greenhouse gas into green fuelDecember 27 - New Zealand Herald |
Insider Transactions View All
| Freidin Aaron filed to sell 268,277 shares at $14. November 19 '24 |
| RAGUSA ROBERT P filed to sell 612,661 shares at $14. October 17 '24 |
| Ofman Joshua J. filed to sell 191,757 shares at $16.2. August 22 '24 |
| Freidin Aaron filed to sell 173,429 shares at $16.2. August 22 '24 |
Similar companies
Read more about Grail (GRAL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, threads followers, twitter followers, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Grail?
The Market Cap of Grail is $596M.
What is the current stock price of Grail?
Currently, the price of one share of Grail stock is $18.57.
How can I analyze the GRAL stock price chart for investment decisions?
The GRAL stock price chart above provides a comprehensive visual representation of Grail's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Grail shares. Our platform offers an up-to-date GRAL stock price chart, along with technical data analysis and alternative data insights.
Does GRAL offer dividends to its shareholders?
As of our latest update, Grail (GRAL) does not offer dividends to its shareholders. Investors interested in Grail should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Grail?
Some of the similar stocks of Grail are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.